Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents

Ali A. Rizvi, Dragana Nikolic, Hanaa Sallam, Giuseppe Montalto, Manfredi Rizzo, Nicola Abate

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalMetabolic Syndrome and Related Disorders
Volume12
Issue number1
DOIs
StatePublished - Feb 1 2014

Fingerprint

Hypolipidemic Agents
Adipokines
Hypoglycemic Agents
Lipoproteins
Adipose Tissue
Angiotensin Receptor Antagonists
Energy Metabolism
Insulin Resistance
Homeostasis
Obesity
Hormones
Glucose
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Adipokines and lipoproteins : Modulation by antihyperglycemic and hypolipidemic agents. / Rizvi, Ali A.; Nikolic, Dragana; Sallam, Hanaa; Montalto, Giuseppe; Rizzo, Manfredi; Abate, Nicola.

In: Metabolic Syndrome and Related Disorders, Vol. 12, No. 1, 01.02.2014, p. 1-10.

Research output: Contribution to journalArticle

Rizvi, Ali A. ; Nikolic, Dragana ; Sallam, Hanaa ; Montalto, Giuseppe ; Rizzo, Manfredi ; Abate, Nicola. / Adipokines and lipoproteins : Modulation by antihyperglycemic and hypolipidemic agents. In: Metabolic Syndrome and Related Disorders. 2014 ; Vol. 12, No. 1. pp. 1-10.
@article{fd90de8b8032430da750fa22be6c16fa,
title = "Adipokines and lipoproteins: Modulation by antihyperglycemic and hypolipidemic agents",
abstract = "Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.",
author = "Rizvi, {Ali A.} and Dragana Nikolic and Hanaa Sallam and Giuseppe Montalto and Manfredi Rizzo and Nicola Abate",
year = "2014",
month = "2",
day = "1",
doi = "10.1089/met.2013.0090",
language = "English (US)",
volume = "12",
pages = "1--10",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Adipokines and lipoproteins

T2 - Modulation by antihyperglycemic and hypolipidemic agents

AU - Rizvi, Ali A.

AU - Nikolic, Dragana

AU - Sallam, Hanaa

AU - Montalto, Giuseppe

AU - Rizzo, Manfredi

AU - Abate, Nicola

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.

AB - Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.

UR - http://www.scopus.com/inward/record.url?scp=84892545867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892545867&partnerID=8YFLogxK

U2 - 10.1089/met.2013.0090

DO - 10.1089/met.2013.0090

M3 - Article

C2 - 24206170

AN - SCOPUS:84892545867

VL - 12

SP - 1

EP - 10

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 1

ER -